touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY

    touchEXPERT OPINIONS for touchDERMATOLOGY

    Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

    The experts

    • Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
    • Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
    • Dr Teresa Amaral, Tübingen University, Tübingen, Germany

      • This touchPODCAST is for healthcare professionals outside of the UK only

      This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

      For further information visit our website: 

      https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

      35 min
    • Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY

      touchEXPERT OPINIONS for touchONCOLOGY 

      Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

      The experts

      • Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
      • Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
      • Dr Teresa Amaral, Tübingen University, Tübingen, Germany

        • This touchPODCAST is for healthcare professionals outside of the UK only

        This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

        For further information visit our website: 

        https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

        35 min
      • Advances in IOL technology and power calculations: Updates and innovations from 2024

        touchFOCUS for touchOPHTHALMOLOGY

        Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology.

        The expert

        • Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA

          • This touchPODCAST is for HCPs only.

          This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME.


          For further information visit our website: www.touchophthalmology.com/

          14 min
        • Supporting healing in epidermolysis bullosa: Innovations and new directions for care

          touchFOCUS for touchDERMATOLOGY


          Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach.

          The expert:

          • Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA

            • This touchPODCAST is for HCPs outside the UK. 


            This activity is funded by an independent medical education grant from Chiesi USA Inc. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: touchDERMA.com

            19 min
          • Primary biliary cholangitis: Appraising the changing therapeutic landscape

            touchEXPERT OPINIONS for touchIMMUNOLOGY

            Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. 

            The expert

            Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA

            This touchPODCAST is for HCPs only.

            This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape

            36 min
          • Primary biliary cholangitis: Appraising the changing therapeutic landscape

            touchEXPERT OPINIONS for touchENDOCRINOLOGY

            Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. 

            The expert

            Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA

            This touchPODCAST is for HCPs only.

            This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website:  https://touchendocrinologyime.org/primary-biliary-cholangitis-therapeutic-landscape

            36 min
          • touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

            touchMDT for touchONCOLOGY


            Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

            The multidisciplinary team

            • Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
          • Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
          • Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
          • Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
          • Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

            • This touchPODCAST is for HCPs outside the UK.


            This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: 

            www.touchONCOLOGY.com 

            14 min
          • touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3

            touchMDT for touchONCOLOGY


            Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

            The multidisciplinary team

            • Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
          • Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
          • Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
          • Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
          • Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

            • This touchPODCAST is for HCPs outside the UK.


            This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: 

            www.touchONCOLOGY.com 

            17 min
          • touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

            touchMDT for touchRESPIRATORY


            Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

            The multidisciplinary team

            • Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
          • Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
          • Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
          • Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
          • Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

            • This touchPODCAST is for HCPs outside the UK.


            This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: 

            www.touchRESPIRATORY.com

            14 min
          • touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3

            touchMDT for touchRESPIRATORY


            Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

            The multidisciplinary team

            • Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
          • Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
          • Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
          • Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
          • Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

            • This touchPODCAST is for HCPs outside the UK.


            This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

            For further information visit our website: 

            www.touchRESPIRATORY.com

            17 min

          About touchPODCAST

          From the publisher's feed

          Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.